Get the Stockscreener App
2.64
3.13%
+0.08
Rezolute Inc stock is currently priced at $2.64, with a 24-hour trading volume of 213.89K.
It has seen a +3.13% increased in the last 24 hours and a -18.52% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $2.58 pivot point. If it approaches the $2.68 resistance level, significant changes may occur.
Previous Close:
$2.56
Open:
$2.55
24h Volume:
213.89K
Market Cap:
$105.96M
Revenue:
-
Net Income/Loss:
$-56.83M
P/E Ratio:
-2.64
EPS:
-1
Net Cash Flow:
$-53.00M
1W Performance:
-11.71%
1M Performance:
-18.52%
6M Performance:
+222.82%
1Y Performance:
+22.79%
1D Range:
$2.51
$2.7307
52W Range:
$0.72
$3.69
Rezolute Inc Stock (RZLT) Company Profile
Name
Rezolute Inc
Sector
Industry
Phone
650 206 4507
Address
201 Redwood Shores Parkway, Suite 315, Redwood City
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-22 | Resumed | Canaccord Genuity | Buy |
| Jun-15-22 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-08-21 | Initiated | ROTH Capital | Buy |
| May-27-21 | Initiated | Oppenheimer | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
Rezolute Inc Stock (RZLT) Latest News
HC Wainwright Reiterates Buy Rating for Rezolute (NASDAQ:RZLT) - MarketBeat
MarketBeat
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update - 15.05.2024 - wallstreet:online
wallstreet:online
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update - Investing.com South Africa
Investing.com South Africa
Rezolute, Inc. (RZLT) Upgraded to Buy: Here's Why - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Vivo Capital LLC Boosts Position in Rezolute, Inc. (NASDAQ:RZLT) - MarketBeat
MarketBeat
Jones Trading sets Rezolute share target at $10, initiates with Buy - Investing.com Nigeria
Investing.com Nigeria
Rezolute Inc Stock (RZLT) Financials Data
Rezolute Inc (RZLT) Net Income 2024
RZLT net income (TTM) was -$56.83 million for the quarter ending December 31, 2023, a -29.11% decrease year-over-year.
Rezolute Inc (RZLT) Cash Flow 2024
RZLT recorded a free cash flow (TTM) of -$53.00 million for the quarter ending December 31, 2023, a -28.30% decrease year-over-year.
Rezolute Inc (RZLT) Earnings per Share 2024
RZLT earnings per share (TTM) was -$1.10 for the quarter ending December 31, 2023, a +26.75% growth year-over-year.
Rezolute Inc Stock (RZLT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Evans Daron | CFO |
Mar 15 '24 |
Buy |
1.69 |
20,000 |
33,830 |
20,000 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Mar 14 '24 |
Buy |
1.88 |
10,000 |
18,800 |
10,000 |
| Evans Daron | CFO |
Mar 08 '24 |
Buy |
1.93 |
50,000 |
96,345 |
120,900 |
| Kim Young-Jin | Director |
Mar 07 '24 |
Buy |
1.91 |
36,503 |
69,859 |
115,450 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Mar 07 '24 |
Buy |
1.85 |
500 |
925 |
500 |
| Elam Nevan C | CEO |
Feb 26 '24 |
Buy |
1.68 |
5,000 |
8,400 |
7,817 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Feb 26 '24 |
Buy |
1.70 |
2,000 |
3,400 |
42,552 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Feb 23 '24 |
Buy |
1.69 |
6,000 |
10,140 |
40,552 |
| Evans Daron | CFO |
Feb 16 '24 |
Buy |
1.30 |
41,900 |
54,411 |
70,900 |
| Evans Daron | CFO |
Feb 16 '24 |
Buy |
1.37 |
9,000 |
12,330 |
4,500 |
About Rezolute Inc
Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for rare and metabolic diseases in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also develops RZ402, a small molecule plasma kallikrein inhibitor, which is in preclinical stage for the treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
0.77%
1.20%
Cap:
|
Volume (24h):